FDA — authorised 19 August 1974
- Marketing authorisation holder: APOTHECON
- Status: approved
FDA authorised Cefradex on 19 August 1974
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 19 August 1974.
APOTHECON holds the US marketing authorisation.